about
Genetically modified T cells in cancer therapy: opportunities and challengesGenetically modified T-cell therapy for osteosarcomaSwitch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.SHP-1 phosphatase activity counteracts increased T cell receptor affinity.Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer.Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.Current strategies in immunotherapy for acute myeloid leukemia.Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.Mobilizing and evaluating anticancer T cells: pitfalls and solutions.CAR T cells: driving the road from the laboratory to the clinic.Genetically modified T cells to target glioblastoma.Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in miceDevelopment of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them.A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.When transgenes shape immunity: cancer immune-gene therapy.
P2860
Q27026627-3D4F55DB-AB0F-4B90-9794-0FF01F773873Q36198232-44B25D6D-8A0E-4213-BBAF-C9F36C94D02CQ36551673-4D3088C1-EFDE-4134-8E31-AD8B8328F072Q36638160-FE56309E-283E-4F41-8E64-5BC506EF1B9EQ37233539-CAD88587-2A41-431C-B837-A2D59F8787F1Q37713393-53CF4C70-966E-4305-A43F-A810989E0581Q38068967-349FBD38-F47C-4887-9E67-08039D004988Q38117268-247B8CA1-A20C-4495-A693-B9A2343CAE76Q38152795-33E5D10F-0984-4AB7-81F9-4F882FA5050BQ38170499-3073BD94-BCBD-4F9F-811A-E5A5803DE61DQ38178690-FA89B619-0ECD-4CD0-9BFF-AABA45D9364BQ38258842-67200510-69BA-4D9F-95D2-1EB6A087CF46Q41879726-6D389A20-39F7-4B72-B657-B53C1D544AF7Q41948139-AD5AE397-98E8-4BBC-B16F-57FBCE792D74Q42233234-F393DCD8-A7F9-496B-9ABE-88971E033013Q42244370-5FE6A349-B29A-48FC-BF4B-E56F6C99122CQ45880014-DD026FB1-8EA0-40B2-9548-4AA995DD2A5A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges in T cell receptor gene therapy.
@en
type
label
Challenges in T cell receptor gene therapy.
@en
prefLabel
Challenges in T cell receptor gene therapy.
@en
P2093
P2860
P356
P1476
Challenges in T cell receptor gene therapy
@en
P2093
Benjamin J Uttenthal
Hans J Stauss
Ignatius Chua
P2860
P304
P356
10.1002/JGM.2637
P577
2012-06-01T00:00:00Z